USSTOCK.TODAY
Weekend. Closed
Log in Sign up

Amgen vs. Vertex Pharmaceuticals: A Healthcare Investment Comparison

The Motley Fool +1 · ·by G4L

VRTX Vertex Pharmaceuticals Inc
$538.60 -0.74%
View chart & analysis →
  1. 1Amgen recorded $38.9 billion in revenue for the 12 months ended September 30, 2026.
  2. 2Amgen's revenue showed an 8.3% year-over-year growth for the 12 months ended September 30, 2026.
  3. 3Vertex Pharmaceuticals recently launched Alektra.

So what's the key point?

Amgen generated $38.9 billion in revenue over one year, growing compared to last year. Vertex Pharmaceuticals released a new drug to the market.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Vertex Pharmaceuticals Q3 revenue increased, but earnings per share missed expectations Earnings Whispers +1 · Nov 3Vertex Pharmaceuticals Q3 Revenue Up 12% · Annual Guidance Raised The Motley Fool +1 · Nov 3Amgen and Vertex Pharmaceuticals: Economies of Scale and Steady Revenue Growth The Motley Fool +1 · Oct 28
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news